Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$954M |
| 2 |
Salesforce
CRM
|
+$683M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$620M |
| 4 |
HCA Healthcare
HCA
|
+$560M |
| 5 |
Netflix
NFLX
|
+$445M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$861M |
| 2 |
Incyte
INCY
|
+$755M |
| 3 |
NVIDIA
NVDA
|
+$655M |
| 4 |
Charles Schwab
SCHW
|
+$534M |
| 5 |
MetLife
MET
|
+$373M |
Sector Composition
| 1 | Financials | 19.84% |
| 2 | Technology | 15.57% |
| 3 | Industrials | 8.44% |
| 4 | Healthcare | 8.44% |
| 5 | Energy | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5901
Century Therapeutics
IPSC
$43.3M
| $10K | ﹤0.01% |
2,991
+1,457
| +95% | +$4.87K |
|
5902
LiveWire
LVWR
$986M
| $10K | ﹤0.01% |
817
+802
| +5,347% | +$9.82K |
|
5903
MarketWise
MKTW
$49.2M
| $10K | ﹤0.01% |
251
+172
| +218% | +$6.85K |
|
5904
Noodles & Co
NDLS
$30.7M
| $10K | ﹤0.01% |
3,042
-476
| -14% | -$1.57K |
|
5905
Invesco 0-5 Yr US TIPS ETF
PBTP
$74.9M
| $10K | ﹤0.01% |
424
-11,821
| -97% | -$279K |
|
|
PCM
5906
PCM Fund
PCM
$79.9M
| $10K | ﹤0.01% |
1,057
| – | – |
|
5907
PDS Biotechnology
PDSB
$54.5M
| $10K | ﹤0.01% |
1,984
+1,734
| +694% | +$8.74K |
|
|
PGP
5908
PIMCO Global StockPLUS & Income Fund
PGP
$99.4M
| $10K | ﹤0.01% |
1,377
-1,433
| -51% | -$10.4K |
|
5909
ProMIS Neurosciences
PMN
$22.8M
| $10K | ﹤0.01% |
2,493
+293
| +13% | +$1.18K |
|
5910
Provident Bancorp
PVBC
$226M
| $10K | ﹤0.01% |
1,189
+361
| +44% | +$3.04K |
|
5911
Skillsoft
SKIL
$108M
| $10K | ﹤0.01% |
418
+165
| +65% | +$3.95K |
|
5912
Xtrackers S&P 500 Value ESG ETF
SNPV
$7.24M
| $10K | ﹤0.01% |
376
-4,381
| -92% | -$117K |
|
|
SOL
5913
Emeren Group
SOL
$96.5M
| $10K | ﹤0.01% |
2,575
+2,416
| +1,519% | +$9.38K |
|
|
THRD
5914
DELISTED
Third Harmonic Bio
THRD
| $10K | ﹤0.01% |
2,126
+1,420
| +201% | +$6.68K |
|
5915
Tourmaline Bio
TRML
$1.22B
| $10K | ﹤0.01% |
344
+215
| +167% | +$6.25K |
|
5916
Trevi Therapeutics
TRVI
$1B
| $10K | ﹤0.01% |
+4,343
| New | +$10K |
|
5917
VirnetX
VHC
$74.7M
| $10K | ﹤0.01% |
997
-289
| -22% | -$2.9K |
|
5918
YPF
YPF
$10.7B
| $10K | ﹤0.01% |
700
-1,000
| -59% | -$14.3K |
|
|
ABLD
5919
Abacus FCF Real Assets Leaders ETF
ABLD
$59.1M
| $10K | ﹤0.01% |
+390
| New | +$10K |
|
|
PMD
5920
DELISTED
Psychemedics Corporation
PMD
| $10K | ﹤0.01% |
+2,145
| New | +$10K |
|
|
LBC
5921
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $10K | ﹤0.01% |
1,070
+239
| +29% | +$2.23K |
|
|
MDWT
5922
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $10K | ﹤0.01% |
+392
| New | +$10K |
|
|
PRTK
5923
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $10K | ﹤0.01% |
4,776
+4,276
| +855% | +$8.95K |
|
|
EMBK
5924
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $10K | ﹤0.01% |
3,416
+2,386
| +232% | +$6.99K |
|
5925
iPath Select MLP ETN
ATMP
$505M
| $9K | ﹤0.01% |
437
-441
| -50% | -$9.08K |
|